Andere talen Verona Pharma plc

Aandelen

VRNA

US9250501064

Beurs gesloten - Nasdaq Andere beurzen 22:00:01 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
15,57 ^USD	-0,95%		-3,89%	-21,68%

22/04	Europese aandelen verhandeld in de VS als American Depositary Receipts veren op in de maandaghandel	MT
16/04	Europese aandelen verhandeld in VS als American Depositary Receipts lager in dinsdaghandel	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	22/04
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	16/04
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	05/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	04/04
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	26/03
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading	25/03
Verona Pharma : Notice and Proxy Statement AGM 2024	21/03
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	21/03
Verona Pharma : Notice and Proxy Statement AGM 2024	20/03
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	20/03
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	14/03
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	13/03
Andrew Fisher Joins Verona Pharma as General Counsel	04/03
Verona Pharma plc Announces Management Changes	04/03
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat	01/03
Verona Pharma Shares Rise After Narrower-Than-Expected Q4 Loss	29/02
Verona Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29/02
Verona Pharma plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading	27/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Verona Pharma plc

Aandelen

VRNA

US9250501064

Andere talen

Filters